Ali Selda, Udrea Ruxandra, Boustani Rama, Puiu Ionela-Andreea, Corcea Sabina Loredana, Spiru Luiza
Department of Allergology "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Department of Allergy and Clinical Immunology, "Dr. Carol Davila" Nephrology Clinical Hospital, Bucharest, Romania.
Arch Clin Cases. 2022 Jul 7;9(2):80-88. doi: 10.22551/2022.35.0902.10208. eCollection 2022.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are reported to be the leading cause of drug hypersensitivity reactions. The aim of this study was to characterize a cohort of patients with NSAID hypersensitivity and establish if there are any differences between two groups of adult patients, under 55 years old and over 55 years old, and identify safe alternative options.
Patients with NSAID hypersensitivity who were referred to a single tertiary Allergy center from January 2019 to December 2021 were included. Clinical information was obtained from a review of medical records.
A total of 135 patients with a history of NSAID-induced hypersensitivity reactions were included, 80 patients under 55 years old and 55 patients older than 55. Most of the patients enrolled were female (80.74%) and the mean age was 50.21 years, ranging from 18 to 78 years old. The time interval between the first reaction and the allergy work-up was longer in the older group (average timeframe 6.87 years) than in the younger group (average timeframe 3.77 years). The main culprit was metamizole in both groups. An oral provocation test to paracetamol was performed in most of the patients who tolerated the intake of 1000 mg, except for 2 patients who developed angioedema.
Angioedema was the most encountered symptom in our population. Age does not influence the allergy work-up of patients with a history of NSAID-induced hypersensitivity reactions. The drug provocation challenge remains the gold standard for finding a suitable alternative in patients with NSAID-induced hypersensitivity.
据报道,非甾体抗炎药(NSAIDs)是药物过敏反应的主要原因。本研究的目的是对一组非甾体抗炎药过敏患者进行特征描述,确定两组成年患者(55岁以下和55岁以上)之间是否存在差异,并确定安全的替代选择。
纳入2019年1月至2021年12月转诊至单一三级过敏中心的非甾体抗炎药过敏患者。通过查阅病历获取临床信息。
共纳入135例有非甾体抗炎药引起的过敏反应病史的患者,其中80例年龄在55岁以下,55例年龄在55岁以上。大多数入组患者为女性(80.74%),平均年龄为50.21岁,年龄范围为18至78岁。老年组从首次反应到进行过敏检查的时间间隔(平均时间为6.87年)比年轻组(平均时间为3.77年)更长。两组的主要致病药物均为安乃近。除2例发生血管性水肿的患者外,大多数耐受摄入1000mg对乙酰氨基酚的患者都进行了口服激发试验。
血管性水肿是我们研究人群中最常见的症状。年龄不影响有非甾体抗炎药引起的过敏反应病史患者的过敏检查。药物激发试验仍然是为非甾体抗炎药过敏患者寻找合适替代药物的金标准。